Skip to main content
Journal cover image

Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations

Publication ,  Journal Article
Baba, T; Mori, S; Matsumura, N; Bernardini, M; Fujii, S; Berchuck, A; Murphy, SK
Published in: GYNECOLOGIC ONCOLOGY
March 1, 2008

Duke Scholars

Published In

GYNECOLOGIC ONCOLOGY

ISSN

0090-8258

Publication Date

March 1, 2008

Volume

108

Issue

3

Start / End Page

S72 / S72

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Baba, T., Mori, S., Matsumura, N., Bernardini, M., Fujii, S., Berchuck, A., & Murphy, S. K. (2008). Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY, 108(3), S72–S72.
Baba, T., S. Mori, N. Matsumura, M. Bernardini, S. Fujii, A. Berchuck, and S. K. Murphy. “Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations.” GYNECOLOGIC ONCOLOGY 108, no. 3 (March 1, 2008): S72–S72.
Baba T, Mori S, Matsumura N, Bernardini M, Fujii S, Berchuck A, et al. Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY. 2008 Mar 1;108(3):S72–S72.
Baba, T., et al. “Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, Mar. 2008, pp. S72–S72.
Baba T, Mori S, Matsumura N, Bernardini M, Fujii S, Berchuck A, Murphy SK. Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2008 Mar 1;108(3):S72–S72.
Journal cover image

Published In

GYNECOLOGIC ONCOLOGY

ISSN

0090-8258

Publication Date

March 1, 2008

Volume

108

Issue

3

Start / End Page

S72 / S72

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis